Correction to: npj Vaccines https://doi.org/10.1038/s41541-021-00312-9, published online 19 April 2021
In the original version of this article, Table 2 was missing from the PDF version. The PDF version has now been corrected. The HTML version of this article did not need correcting.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Olsen, A.W., Rosenkrands, I., Holland, M.J. et al. Publisher Correction: A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars. npj Vaccines 7, 104 (2022). https://doi.org/10.1038/s41541-022-00521-w
Published:
DOI: https://doi.org/10.1038/s41541-022-00521-w
